The Revlon/UCLA Breast Center combines the latest in diagnostic studies, treatment, research and support care to provide patients with cutting-edge treatments and compassionate care. At the Breast Center, care is tailored to each patient's unique needs, creating an environment where women feel well cared for as they receive the highest quality of care and treatment.
The team at the Breast Center includes surgeons, radiation oncologists, medical oncologists, plastic surgeons, breast radiologists, breast pathologists, obstetric gynecology specialists, a dietitian, geneticists, social workers and psychologists. Our team’s comprehensive care plans provide patients with state-of-the-art treatments and personalized high quality care.
Services offered at Revlon/UCLA Breast Center
- Diagnostic Clinic
The Diagnostic Clinic at the Revlon/UCLA Breast Center is designed for women who are facing a range of new breast-related concerns or conditions, including but not limited to a breast cancer diagnosis requiring surgical treatment, abnormal breast imaging studies or a palpable breast lump. Learn more »
- High Risk Breast Clinic
The UCLA High Risk Breast Clinic in Santa Monica offers patients who are at high risk for breast cancer a tailored prevention, screening and risk-reduction care strategy. Eligible patients meet with a medical oncologist and oncology nurse practitioner for personalized high-risk counseling. Depending on their personal history and associated risk level, patients may also receive information on complementary therapies for primary and secondary prevention. If needed, patients will also have access to our onsite genetic counselor. Learn more »
- Comprehensive Breast Cancer Center
The advances in healthcare delivery and innovative technologies continue to lay new ground in managing breast cancer. The Revlon/UCLA Breast Center is taking the lead to develop programs that provide precision medicine and personalized care to our patients. The programs are listed below.
- Multidisciplinary Prophylactic Mastectomy Program
Women at significantly increased risk of developing breast cancer such as those with a genetic predisposition or those with a high-risk breast lesion -- may choose risk reduction prophylactic mastectomy with immediate reconstruction (with or without a strong family history of the disease). The program offers these women psychological counseling to better understand the decision they make and their realistic expectations for the chosen surgery. The program also provides these women a team of breast surgeons, plastic surgeons and geneticists, to assist them in achieving the best long-term outcome.
- Young Women’s Breast Cancer Program
Young women with breast cancer often face unique concerns and challenges, including issues related to genetic heritage, fertility, high-risk pregnancies, changes in physical appearance post-treatment, family responsibilities and the impact on their interrupted careers. Their cancer may also have unique features that require different treatment approaches. This program will offer young women with breast cancer a personalized care plan that is comprehensive, convenient and easy to follow.
- Triple-Negative Breast Cancer Program
Triple-negative breast cancer (TNBC) refers to a type of breast cancer that lacks the expression of estrogen receptors, progesterone receptors and human epidermal growth factor receptor 2 (HER2). This means the cancer does not respond to therapies that target these receptors, such as Tamoxifen and Herceptin. Triple-negative breast cancers account for roughly 10-20 percent of breast cancers and they more frequently affect women that are younger, African American or Hispanic, or carriers of a mutated BRCA1 or BRCA2 gene. Triple-negative breast cancer is an aggressive type of breast cancer that often requires intense and prompt treatment. This program offers women with TNBC an immediate diagnostic evaluation, treatment consultations with multidisciplinary experts, as well as genetic evaluation and wellness support services.
- HER2 Positive Breast Cancer Program
HER2 positive breast cancer represents a group of aggressive cancers characterized by rapid growth and frequent metastasis. The discovery and groundbreaking treatment of HER2 positive breast cancer was in fact pioneered by UCLA doctors and researchers. Today, treatment for HER2 positive breast cancer continues to improve with new drugs that will be available to patients in the HER2 Positive Breast Cancer Program. This program is dedicated to developing and providing the most promising treatment for women with HER2 positive breast cancer. A team of experts will discuss various treatment options and clinical trials to determine the best fit for each woman’s unique condition.
- Early Breast Cancer Program
The majority of breast cancer cases in the United States are detected during earlier stages of the disease, when tumors are relatively small and may not have lymph node involvement. Other women, however, may have large but slow growing tumors that are positive for estrogen and progesterone receptors but negative for HER2. The goal of this program is to offer affected women treatment that focuses on selecting the best treatment available for each woman without taxing them with overtreatment.
- Multidisciplinary Program
A key component of the Comprehensive Breast Cancer Clinic at the Revlon/UCLA Breast Center is the Multidisciplinary Program. Patients with newly diagnosed or recurrent breast cancer can be seen in one setting by a team of specialists that will provide them with personalized recommendations on diagnostic studies, treatment and supportive care services. Learn more »
All women with newly diagnosed breast cancer will be assigned to a program that best fits their type of cancer and condition. The programs provide women with the opportunity to choose their own doctors and decide when they want to be seen, enabling a more flexible and efficient way to gather all the information they need. Each program incorporates precision medicine, tailored services and patient-focused education.
- Clinical Trials
Clinical trials available at the Breast Center are designed to test the best way to deliver specific types of breast cancer treatments that will reduce post-treatment recurrence and improve patient wellness. Learn more »
The Revlon/UCLA Breast Center is a leader in investigating more effective ways to diagnose and treat breast cancer, as well as lower the risk of recurrence. There are a range of clinical research projects at the Breast Center currently, including studies on the role of biomarkers in detecting early stage breast cancer and developing new drugs, guiding treatment choices and improving survival outcomes after treatment. Learn more »
The Revlon/UCLA Breast Center also works closely with the UCLA Iris Cantor Center for Breast Imaging, the Barbara Kort Women’s Imaging Center and the Simms/Mann UCLA Center for Integrative Oncology, offering cancer patients educational programs and support groups. Reflections Boutique (located at 200 UCLA Medical Plaza) offers women a place to shop for wigs, prostheses, hats and other items.
- Breast Cancer Tumor Board
Our Tumor Board, comprised of a multidisciplinary specialty panel, prospectively reviews all breast cancer cases treated by Revlon/UCLA Breast Center surgeons. The recommendations regarding further diagnostic studies and/or treatment will be communicated to patients by their surgeons within two weeks of their surgery. Learn more »